Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Oct 25;63(8):1313–1324. doi: 10.1136/gutjnl-2012-304058

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/

PMC Copyright notice

Protective effects of 3-benzyl-6-chloro-2-pyrone (3-BCP) on biomarkers of fatty acid ethyl ester-induced acute pancreatitis (FAEE-AP) induced by palmitoleic acid (POA)/ethanol. FAEE-AP was induced by two intraperitoneal injections of ethanol (1.35 g/kg) and POA (150 mg/kg). The effects of inhibition of oxidative metabolism of ethanol (OME) with 4-methylpyrazole (4-MP; 10 mg/kg) or non-OME with 3-BCP (30 mg/kg), given on the first injection of POA/ethanol, were assessed on (A) Serum amylase, (B) Pancreatic trypsin activity, (C) Pancreatic myeloperoxidase activity (normalised) and (D) Serum interleukin-6 (IL-6). Control mice received saline injections only. Mice were sacrificed 24 h after the first injection. *p<0.05 compared to both saline and POA controls, ^#p<0.05 compared to the POA/ethanol group. Values are mean±SE of 6 mice.

HHS Vulnerability Disclosure